Philadelphia Chromosome Mosaicism Due to Additional Cytogenetic Abnormalities in Chronic Myeloid Leukemia Might Adversely Affect Prognosis and Response to Imatinib
Restricted accessAbstractFirst published online March, 2007
Philadelphia Chromosome Mosaicism Due to Additional Cytogenetic Abnormalities in Chronic Myeloid Leukemia Might Adversely Affect Prognosis and Response to Imatinib